≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

See its core counterpart CD2_INSITU_VAGINA_EXALLC for full statistics.

Carcinoma in situ of vagina

DOID Endpoint Browser

CD2_INSITU_VAGINA

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

only females

293373

2. Check conditions

  • not C3_VAGINA
293313

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D07.2&
  • Hospital discharge: ICD-9 — 2333A
  • Cause of death: ICD-10 — D07.2&
  • Cause of death: ICD-9 — 2333A
  • Cancer registry: Topography ICD-O-3 — C52
  • Cancer registry: Morphology ICD-O-3 — ANY
  • Cancer registry: Behaviour codes — 2

3 out of 7 registries used, show all original rules.

147

4. Check minimum number of events

None

147

5. Include endpoints

None

147

6. Filter based on genotype QC (FinnGen only)

147

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF9
Parent code in ICD-10
D07
Name in latin
Carcinoma in situ prostatae

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 147 147 -
Unadjusted period prevalence (%) 0.05 0.05 -
Median age at first event (years) 57.50 57.50 -

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
137
Matched controls
1370
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
8077/2-C52.9
ICD-O-3
Squamous intraepithelial neoplasia, high grade of vagina, NOS
+∞
155.4
118
*
LEB00
NOMESCO Finland
Biopsy of vagina
342.8
120.7
109
15
LEB30
NOMESCO Finland
Destruction of lesion of vaginal mucosa
931.6
108.9
93
*
ULA02
NOMESCO Finland
Kolposcopy
219.8
107.1
131
123
N89.2
ICD-10 Finland
Severe vaginal dysplasia, not elsewhere classified
746.9
80.9
72
*
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
38.0
70.9
112
144
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
32.0
66.0
104
122
N89.1
ICD-10 Finland
Moderate vaginal dysplasia
526.6
65.4
60
*
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
25.3
53.0
82
76
N89.0
ICD-10 Finland
Mild vaginal dysplasia
198.4
31.1
31
*
LFB00
NOMESCO Finland
Biopsy of vulva or perineum
24.3
30.6
44
26
LDC03
NOMESCO Finland
Conisation of cervix uteri using diathermy or laser
15.1
29.5
52
53
LDA10
NOMESCO Finland
Curettage of cervix uteri
14.6
27.6
49
50
8077/2-C53.9
ICD-O-3
Squamous intraepithelial neoplasia, high grade of cervix uteri
30.1
20.5
27
11
N90.2
ICD-10 Finland
Severe vulvar dysplasia, not elsewhere classified
81.9
19.3
21
*
N87.0
ICD-10 Finland
Mild cervical dysplasia
15.1
19.1
32
27
N87.2
ICD-10 Finland
Severe cervical dysplasia, not elsewhere classified
17.3
17.8
28
20
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
4.8
17.0
90
388
LEB10
NOMESCO Finland
Excision of lesion of vagina
68.5
16.2
18
*
D07.2
ICD-10 Finland
Carcinoma in situ: Vagina
+∞
14.9
14
*
8077/2-C51.9
ICD-O-3
Squamous intraepithelial neoplasia, high grade of vulva, NOS
118.7
10.6
11
*
N90.1
ICD-10 Finland
Moderate vulvar dysplasia
43.5
10.1
12
*
A63.0
ICD-10 Finland
Anogenital (venereal) warts
9.6
10.0
20
24
R87.5
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal microbiological findings
20.3
9.1
13
7
LDB20
NOMESCO Finland
Electrocoagulation or laser therapy of cervix uteri
15.4
8.9
14
10
LFB10
NOMESCO Finland
Excision of lesion of vulva or perineum
12.8
8.3
14
12
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
4.2
7.4
28
78
D06BB10
ATC
imiquimod; topical
7.4
7.1
16
24
N87.1
ICD-10 Finland
Moderate cervical dysplasia
7.1
6.9
16
25
N90.0
ICD-10 Finland
Mild vulvar dysplasia
17.8
6.9
10
6
LFB20
NOMESCO Finland
Destruction of lesion of vulva or perineum
23.9
6.8
9
*
ZXC10
NOMESCO Finland
Use of laser
10.8
6.7
12
12
LFC00
NOMESCO Finland
Partial excision of vulva
73.1
6.5
7
*
R87.7
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal histological findings
+∞
6.3
6
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.6
6.1
60
319

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3025130) Human papilloma virus identified in Specimen
50
28
26.55
64.99
4.7
1.8
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
61
73
13.57
51.19
4.2
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
116
351
11.93
43.46
4.4
1.5
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
33
9
46.69
27.55
5.9
2.0
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
118
568
6.46
21.31
6.0
2.0
—
—
—
0
0
(4035726)
44
119
4.85
15.77
1.3
1.3
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
98
579
3.08
9.54
4.6
3.8
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
68
362
2.63
7.57
2.0
2.0
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
71
424
2.30
5.77
4.4
2.9
mmol/l
2.4
2.4
0.30
55
369
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
53
279
2.41
5.76
2.1
2.0
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
10
20
5.29
4.85
1.0
1.8
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
30
137
2.49
4.33
3.3
2.2
%
25.6
22.0
0.67
25
110
(3019309) Folate [Moles/volume] in Red Blood Cells
37
190
2.27
4.11
1.7
1.7
nmol/l
1149.6
1190.4
0.10
28
144
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
31
148
2.39
4.06
1.7
1.8
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
11
28
4.17
4.06
4.3
4.0
mmol/l
25.5
25.1
0.24
11
28
(3026008) Bacteria identified in Urine by Culture
63
402
1.99
3.96
3.9
2.6
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
76
522
1.94
3.82
6.3
4.7
mmol/l
1.2
1.2
0.76
61
475
(3019225) pH of Specimen
25
111
2.51
3.81
4.6
3.9
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
49
289
2.04
3.81
3.6
2.6
umol/l
306.7
7550.7
1.79
41
249
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
32
160
2.28
3.76
1.8
1.9
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
33
168
2.24
3.72
2.1
1.7
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
62
401
1.94
3.69
5.7
2.9
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
71
490
1.87
3.40
7.3
3.8
g/l
35.9
36.2
0.22
64
456
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
78
559
1.84
3.28
2.8
2.2
nmol/l
79.3
80.1
0.10
65
497
(3022313) Gas panel - Capillary blood
11
33
3.52
3.26
4.5
3.5
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
29
148
2.20
3.23
3.8
4.4
%
32.2
34.0
0.41
20
98
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
34
185
2.09
3.23
1.4
1.6
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
66
454
1.82
3.13
2.1
1.9
pmol/l
100.9
102.8
0.11
32
213
(3002256) Pathology report gross observation
32
173
2.09
3.08
1.4
1.2
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
7
12
6.06
3.06
3.6
2.3
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
59
396
1.82
3.01
8.6
4.9
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
118
979
2.04
3.00
12.2
6.8
u/l
75.6
75.5
0.01
110
909
(3013707) Erythrocyte sedimentation rate by Westergren method
118
979
2.04
3.00
5.3
3.9
mm/h
15.8
11.1
1.88
105
888
(36304419) Bacteria [Presence] in Urine
49
311
1.86
2.98
4.5
2.7
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
62
425
1.79
2.94
7.4
6.6
inr
1.2
1.1
0.14
14
130
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
16
65
2.64
2.90
1.3
1.3
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
6
9
6.89
2.89
1.0
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
9
23
4.10
2.82
2.1
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
9
23
4.10
2.82
2.1
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
6
8.57
2.77
1.0
1.3
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
5
6
8.57
2.77
3.6
2.3
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
83
627
1.74
2.76
4.6
3.5
estimate
0.0
0.0
0.00
13
113
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
33
189
1.96
2.71
5.0
2.4
e6/l
1.3
1.1
0.10
19
100
(3052851) Hemolysis interference index of Serum or Plasma
10
32
3.28
2.70
3.2
2.8
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
11
38
3.05
2.64
1.6
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
50
331
1.77
2.61
4.0
2.7
mmol/l
6.9
7.0
0.04
31
275
(3021601) Nitrite [Presence] in Urine by Test strip
82
624
1.71
2.60
6.3
4.9
estimate
0.0
0.0
0.00
12
117
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
18
82
2.36
2.60
1.8
1.7
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
38
234
1.84
2.50
3.2
2.5
e6/l
5.9
6.1
0.05
32
209
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
15
64
2.50
2.48
1.6
1.6
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
92
730
1.70
2.43
14.7
9.0
e9/l
3.7
3.8
0.28
84
644
(3026389) Candida sp identified in Specimen by Organism specific culture
6
12
5.16
2.42
1.7
1.5
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
6
12
5.16
2.42
1.0
1.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
35
212
1.85
2.42
1.7
1.8
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
77
586
1.66
2.36
8.5
5.4
mmol/l
1.2
1.2
0.70
63
503
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
61
437
1.68
2.36
3.3
3.1
ng/l
25.2
20.2
0.33
36
276
(3035350) Ketones [Presence] in Urine by Test strip
80
618
1.65
2.29
4.6
3.6
estimate
0.0
0.0
0.00
13
114
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
21
110
2.06
2.19
2.5
1.7
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
16
75
2.27
2.18
1.3
1.4
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
5
10
5.13
2.08
3.6
2.2
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
46
316
1.66
2.05
5.2
2.8
e6/l
0.3
0.5
0.74
32
226
(3003396) Base excess in Arterial blood by calculation
20
106
2.03
2.03
4.7
6.0
mmol/l
1.1
1.3
0.12
15
87
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
28
167
1.84
2.03
5.6
2.6
e6/l
5.0
4.3
0.12
14
80
(3013115) Eosinophils [#/volume] in Blood
82
651
1.59
2.01
10.0
5.4
e9/l
0.2
0.2
0.30
73
584
(3002582) Erythrocytes [#/volume] in Urine
49
344
1.64
2.00
5.4
2.9
e6/l
34.9
58.0
0.38
36
252
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
26
152
1.86
2.00
4.7
5.7
—
—
—
0
0
(40758558) Short blood count panel - Blood
46
318
1.65
1.99
10.3
7.2
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
86
692
1.59
1.98
5.5
3.8
mmol/l
6.3
6.3
0.17
81
635
(3020682) Albumin/Creatinine [Ratio] in Urine
47
329
1.63
1.93
5.0
3.6
mg/mmol
29.5
5.3
0.49
19
183
(3045414) Leukocytes [Presence] in Urine
12
52
2.42
1.93
1.3
1.8
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
71
550
1.56
1.90
13.1
8.1
e9/l
0.0
0.0
0.75
59
451
(3019198) Lymphocytes [#/volume] in Blood
80
637
1.56
1.90
9.4
5.3
e9/l
1.7
2.1
1.43
73
573
(3012516) Albumin [Mass/volume] in Urine
45
313
1.63
1.89
4.0
2.9
mg/l
73.4
24.6
0.41
23
180
(3012544) pH of Venous blood
18
95
2.02
1.85
5.1
2.9
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
20
111
1.93
1.79
2.6
1.7
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
47
335
1.59
1.78
4.6
3.7
estimate
0.0
0.0
0.00
12
116
(3006315) Basophils [#/volume] in Blood
78
625
1.53
1.75
9.6
5.2
e9/l
0.0
0.0
0.34
72
550
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
132
1200
1.98
1.74
17.0
10.5
ml/min/173m2
81.2
84.0
0.63
106
989
(3000991) Gas panel - Venous blood
15
76
2.08
1.71
7.7
6.1
—
—
—
0
0
(3009343) pH of Capillary blood
11
49
2.35
1.68
4.5
3.1
—
7.4
—
0
7
(3017143) Hepatitis C virus Ab [Presence] in Serum
23
137
1.80
1.67
1.5
1.4
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
77
621
1.50
1.64
9.7
5.2
e9/l
0.5
0.5
0.39
71
547
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
10
44
2.37
1.57
1.4
1.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
8
33
2.50
1.56
2.3
2.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
45
327
1.54
1.55
1.4
1.5
—
—
—
0
0
(40761535) Cells panel - Urine sediment
17
94
1.91
1.55
4.7
3.6
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
55
418
1.50
1.54
5.7
3.4
e6/l
90.0
92.0
0.01
39
277
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
18
102
1.87
1.53
2.2
3.1
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
37
259
1.57
1.50
6.9
3.3
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
6
23
2.67
1.38
4.2
3.5
u/ml
53.3
80.6
—
6
23
(3023511) Choriogonadotropin [Units/volume] in Urine
0
39
0.00
1.36
0.0
1.3
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
40
292
1.51
1.34
7.9
3.3
%
99.8
98.2
0.19
40
284
(40768443) Skin Pathology biopsy report
10
48
2.16
1.31
1.4
1.2
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
10
48
2.16
1.31
1.5
2.1
u/l
2909.0
9201.8
—
5
16
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
8
35
2.36
1.29
1.1
1.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
62
498
1.42
1.27
5.0
3.5
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
21
133
1.68
1.26
2.3
1.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
6
25
2.46
1.25
1.5
1.0
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
39
291
1.46
1.17
3.5
2.9
ng/l
1650.0
881.1
0.38
33
241
(4010399)
15
88
1.78
1.16
1.6
1.4
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
30
212
1.52
1.16
2.7
2.5
mmol/l
2.5
2.4
0.45
22
183
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
5
20
2.55
1.16
1.2
1.4
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
15
89
1.76
1.12
4.7
4.8
%
0.0
0.0
—
6
17
(3042936) Bacteria identified in Isolate by Culture
23
154
1.59
1.12
2.0
2.0
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
136
1281
1.82
1.10
21.9
11.3
mg/l
19.7
19.1
0.07
104
962
(3022145) Colonoscopy Study observation
23
155
1.57
1.09
1.5
1.2
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
10
52
1.99
1.09
3.8
3.3
mmol/l
24.7
25.2
—
10
52
(3017181) Myelocytes/100 leukocytes in Blood
16
99
1.69
1.05
4.8
4.6
%
0.4
0.8
—
8
25
(3001019) Free T4 and TSH panel - Serum or Plasma
16
99
1.69
1.05
1.6
1.8
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
10
53
1.95
1.04
1.5
1.4
—
—
—
0
0
(3013512) EKG study
43
335
1.40
1.02
3.9
3.5
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
15
92
1.70
1.01
5.0
4.8
%
0.1
0.1
—
7
22
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
20
133
1.58
1.01
2.6
1.5
%
1.4
1.3
0.15
13
119
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
9
49
1.89
1.00
1.2
1.6
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
9
50
1.85
0.98
1.3
1.7
—
—
—
0
0
(3000492) Spirometry study
16
101
1.66
0.98
1.3
1.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
6
28
2.19
0.92
1.3
2.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
13
79
1.71
0.91
1.4
1.4
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
35
268
1.40
0.91
1.6
1.4
nmol/l
22.8
22.7
0.01
28
220
(3015736) pH of Urine
59
492
1.33
0.90
4.8
3.3
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
6
30
2.04
0.88
3.8
2.9
%
178.5
185.4
—
6
30
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
8
46
1.78
0.84
11.3
2.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
6
32
1.91
0.82
1.5
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
39
480
0.74
0.81
2.9
2.8
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
35
274
1.36
0.80
5.4
3.5
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
26
0.00
0.79
0.0
1.6
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
6
34
1.80
0.77
1.0
1.6
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
6
34
1.80
0.77
1.3
1.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
9
53
1.74
0.77
2.6
4.8
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
36
285
1.35
0.77
1.7
1.4
g/l
2.2
2.3
0.12
22
175
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
128
1209
1.45
0.76
4.1
3.8
mmol/l
1.3
1.2
1.32
114
1125
(3004616) Nuclear Ab [Presence] in Serum
5
24
2.12
0.75
1.6
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
5
24
2.12
0.75
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
5
24
2.12
0.75
1.0
1.1
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
37
296
1.33
0.74
1.7
1.7
mg/l
0.9
0.9
0.04
28
225
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
5
25
2.03
0.73
1.2
1.4
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
132
1256
1.50
0.73
4.7
4.3
mmol/l
1.6
1.6
0.46
116
1176
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
5
26
1.95
0.71
4.2
2.0
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
35
282
1.32
0.67
5.6
3.6
kg/l
1.0
1.0
—
6
40
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
36
292
1.31
0.65
1.6
1.5
—
—
—
0
0
(3018418) pH of Serum or Plasma
44
367
1.28
0.65
5.5
3.5
ph
7.4
7.4
—
7
66
(3037522) Nuclear Ab [Titer] in Serum
25
192
1.36
0.65
1.7
1.4
titre
648.9
494.5
—
9
44
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
5
29
1.75
0.64
1.2
1.2
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
95
871
1.26
0.62
7.3
4.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
32
390
0.77
0.61
1.9
1.7
mmol/l
1.2
1.3
0.80
21
334
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
1.5
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
39
324
1.28
0.59
1.3
1.3
u/ml
0.8
1.9
—
9
102
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
132
1265
1.43
0.59
4.7
4.3
mmol/l
4.8
4.9
0.38
118
1189
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
23
0.00
0.59
0.0
1.8
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
38
1.60
0.55
1.0
1.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
138
1335
1.55
0.54
17.8
10.5
—
—
—
0
0
(3044889) 12 lead EKG panel
93
858
1.23
0.54
3.9
3.4
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
9
62
1.48
0.54
3.4
2.4
mmol/l
25.3
25.4
—
9
62
(3022621) pH of Urine by Test strip
12
83
1.49
0.53
2.9
2.3
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
23
183
1.30
0.48
3.3
1.8
ug/g
79.0
84.0
0.07
18
141
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
133
1284
1.38
0.48
5.4
4.8
mmol/l
2.8
2.9
0.29
118
1195
(3041096) Erythrocytes [Presence] in Urine by Automated
42
362
1.22
0.47
3.8
3.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
7
49
1.45
0.46
6.6
6.7
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
12
86
1.43
0.46
1.2
1.3
u/ml
95.1
109.9
0.07
12
80
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
92
858
1.19
0.44
4.3
2.9
u/l
78.8
38.5
0.69
83
809
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
5
31
1.63
0.43
1.0
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
5
31
1.63
0.43
1.0
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
5
31
1.63
0.43
1.0
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
5
31
1.63
0.43
1.0
1.5
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
5
32
1.58
0.42
1.4
1.8
—
—
—
0
0
(4268621)
0
15
0.00
0.41
0.0
1.9
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
0
15
0.00
0.41
0.0
1.9
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(1616796) Gas panel - Central venous blood
0
16
0.00
0.41
0.0
1.5
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
18
142
1.30
0.41
1.3
1.3
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
8
61
1.33
0.40
1.9
1.3
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
5
36
1.40
0.38
1.4
1.3
—
—
—
0
0
(3020891) Body temperature
5
36
1.40
0.38
1.4
4.7
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
6
45
1.35
0.34
1.8
1.9
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
13
103
1.29
0.29
2.9
3.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
11
139
0.77
0.28
1.5
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
10
77
1.32
0.27
1.1
1.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
110
1062
1.14
0.25
4.7
4.3
pmol/l
14.6
14.5
0.10
96
979
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
119
1157
1.15
0.22
6.1
5.2
mmol/mol
38.6
38.8
0.06
104
1083
(3009542) Hematocrit [Volume Fraction] of Blood
120
1168
1.15
0.22
21.7
12.3
%
38.9
39.7
0.49
86
872
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(4027681)
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.4
—
2.0
—
0
10
(4146454)
0
12
0.00
0.21
0.0
3.3
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
10.2
—
0.7
—
0
12
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
11
133
0.81
0.20
1.8
1.7
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
0
14
0.00
0.20
0.0
1.1
—
100.0
—
0
14
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
31
285
1.11
0.16
1.3
1.3
u/ml
1.2
10.7
2.46
11
111
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
84
866
0.93
0.13
3.3
3.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
127
1253
1.10
0.10
4.9
4.3
mmol/l
5.7
5.7
0.02
115
1162
(40768797) Stomach Pathology biopsy report
17
186
0.90
0.10
1.0
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
5
46
1.09
0.09
1.0
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
5
46
1.09
0.09
1.0
1.2
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
5
46
1.09
0.09
2.0
4.0
%
0.8
0.9
—
5
46
(42529406) Shigella sp [Presence] in Stool by Culture
5
47
1.07
0.09
1.0
1.2
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
6
53
1.14
0.09
1.7
2.2
%
0.7
0.7
—
6
53
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
6
56
1.07
0.09
1.7
2.2
%
0.8
1.1
—
6
56
(3004588) Protein electrophoresis panel - Serum or Plasma
7
65
1.08
0.08
1.6
2.9
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
30
284
1.07
0.08
1.3
1.3
iu/ml
18.2
33.7
—
10
102
(3004716) Salmonella sp identified in Stool by Organism specific culture
7
81
0.86
0.07
1.0
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
13
142
0.91
0.06
1.4
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
15
141
1.07
0.03
1.7
1.7
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
11
117
0.94
0.02
3.2
1.8
nmol/l
320.0
380.2
0.46
11
109
(3013139) Helicobacter pylori Ag [Presence] in Stool
10
106
0.94
0.01
1.5
1.3
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
12
114
1.06
0.01
1.3
1.2
iu/ml
44.0
182.5
—
5
52
(36660697) Celiac disease serology panel - Serum
12
114
1.06
0.01
1.3
1.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
123
1234
0.98
0.00
5.5
5.1
mu/l
1.7
1.8
1.10
108
1144
(40760892) CBC W Ordered Manual Differential panel - Blood
31
312
0.99
0.00
5.7
4.7
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
11
115
0.95
0.00
1.5
1.6
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
8
89
0.89
0.00
1.1
1.2
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768793) Breast Pathology biopsy report
6
65
0.92
0.00
1.3
1.3
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
9
93
0.97
0.00
1.4
1.5
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
7
0.00
0.00
0.0
1.3
—
28.0
—
0
7
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
5
58
0.86
0.00
1.0
1.5
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
6
59
1.02
0.00
1.3
1.1
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
66.8
—
0
6
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
10.3
—
0
7
(3004451) EKG impression Narrative
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
19.0
—
0
5
(3028433) Virus identified in Specimen by Culture
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
5
0.00
0.00
0.0
1.0
—
5.5
—
0
5
(3034426) Prothrombin time (PT)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(4198724)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
13.3
—
2197.7
—
0
9
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.0
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
12.9
—
1126.2
—
0
9

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: CD2_INSITU_VAGINA – Carcinoma in situ of vagina

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).